Cargando…

Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms

BACKGROUND: Interleukin‐19 is an immunosuppressive cytokine produced by immune and nonimmune cells, but its role in abdominal aortic aneurysm (AAA) pathogenesis is not known. This study aimed to investigate interleukin‐19 expression in, and influences on, the formation and progression of experimenta...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Hiroki, Xu, Baohui, Xuan, Haojun, Ge, Yingbin, Wang, Yan, Li, Yankui, Wang, Wei, Guo, Jia, Zhao, Sihai, Glover, Keith J., Zheng, Xiaoya, Liu, Shuai, Inuzuka, Kazunori, Fujimura, Naoki, Furusho, Yuko, Ikezoe, Toru, Shoji, Takahiro, Wang, Lixin, Fu, Weiguo, Huang, Jianhua, Unno, Naoki, Dalman, Ronald L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649236/
https://www.ncbi.nlm.nih.gov/pubmed/34459250
http://dx.doi.org/10.1161/JAHA.121.022207
_version_ 1784610950643449856
author Tanaka, Hiroki
Xu, Baohui
Xuan, Haojun
Ge, Yingbin
Wang, Yan
Li, Yankui
Wang, Wei
Guo, Jia
Zhao, Sihai
Glover, Keith J.
Zheng, Xiaoya
Liu, Shuai
Inuzuka, Kazunori
Fujimura, Naoki
Furusho, Yuko
Ikezoe, Toru
Shoji, Takahiro
Wang, Lixin
Fu, Weiguo
Huang, Jianhua
Unno, Naoki
Dalman, Ronald L.
author_facet Tanaka, Hiroki
Xu, Baohui
Xuan, Haojun
Ge, Yingbin
Wang, Yan
Li, Yankui
Wang, Wei
Guo, Jia
Zhao, Sihai
Glover, Keith J.
Zheng, Xiaoya
Liu, Shuai
Inuzuka, Kazunori
Fujimura, Naoki
Furusho, Yuko
Ikezoe, Toru
Shoji, Takahiro
Wang, Lixin
Fu, Weiguo
Huang, Jianhua
Unno, Naoki
Dalman, Ronald L.
author_sort Tanaka, Hiroki
collection PubMed
description BACKGROUND: Interleukin‐19 is an immunosuppressive cytokine produced by immune and nonimmune cells, but its role in abdominal aortic aneurysm (AAA) pathogenesis is not known. This study aimed to investigate interleukin‐19 expression in, and influences on, the formation and progression of experimental AAAs. METHODS AND RESULTS: Human specimens were obtained at aneurysm repair surgery or from transplant donors. Experimental AAAs were created in 10‐ to 12‐week‐old male mice via intra‐aortic elastase infusion. Influence and potential mechanisms of interleukin‐19 treatment on AAAs were assessed via ultrasonography, histopathology, flow cytometry, and gene expression profiling. Immunohistochemistry revealed augmented interleukin‐19 expression in both human and experimental AAAs. In mice, interleukin‐19 treatment before AAA initiation via elastase infusion suppressed aneurysm formation and progression, with attenuation of medial elastin degradation, smooth‐muscle depletion, leukocyte infiltration, neoangiogenesis, and matrix metalloproteinase 2 and 9 expression. Initiation of interleukin‐19 treatment after AAA creation limited further aneurysmal degeneration. In additional experiments, interleukin‐19 treatment inhibited murine macrophage recruitment following intraperitoneal thioglycolate injection. In classically or alternatively activated macrophages in vitro, interleukin‐19 downregulated mRNA expression of inducible nitric oxide synthase, chemokine C‐C motif ligand 2, and metalloproteinases 2 and 9 without apparent effect on cytokine‐expressing helper or cytotoxic T‐cell differentiation, nor regulatory T cellularity, in the aneurysmal aorta or spleen of interleukin‐19–treated mice. Interleukin‐19 also suppressed AAAs created via angiotensin II infusion in hyperlipidemic mice. CONCLUSIONS: Based on human evidence and experimental modeling observations, interleukin‐19 may influence the development and progression of AAAs.
format Online
Article
Text
id pubmed-8649236
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86492362022-01-14 Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms Tanaka, Hiroki Xu, Baohui Xuan, Haojun Ge, Yingbin Wang, Yan Li, Yankui Wang, Wei Guo, Jia Zhao, Sihai Glover, Keith J. Zheng, Xiaoya Liu, Shuai Inuzuka, Kazunori Fujimura, Naoki Furusho, Yuko Ikezoe, Toru Shoji, Takahiro Wang, Lixin Fu, Weiguo Huang, Jianhua Unno, Naoki Dalman, Ronald L. J Am Heart Assoc Original Research BACKGROUND: Interleukin‐19 is an immunosuppressive cytokine produced by immune and nonimmune cells, but its role in abdominal aortic aneurysm (AAA) pathogenesis is not known. This study aimed to investigate interleukin‐19 expression in, and influences on, the formation and progression of experimental AAAs. METHODS AND RESULTS: Human specimens were obtained at aneurysm repair surgery or from transplant donors. Experimental AAAs were created in 10‐ to 12‐week‐old male mice via intra‐aortic elastase infusion. Influence and potential mechanisms of interleukin‐19 treatment on AAAs were assessed via ultrasonography, histopathology, flow cytometry, and gene expression profiling. Immunohistochemistry revealed augmented interleukin‐19 expression in both human and experimental AAAs. In mice, interleukin‐19 treatment before AAA initiation via elastase infusion suppressed aneurysm formation and progression, with attenuation of medial elastin degradation, smooth‐muscle depletion, leukocyte infiltration, neoangiogenesis, and matrix metalloproteinase 2 and 9 expression. Initiation of interleukin‐19 treatment after AAA creation limited further aneurysmal degeneration. In additional experiments, interleukin‐19 treatment inhibited murine macrophage recruitment following intraperitoneal thioglycolate injection. In classically or alternatively activated macrophages in vitro, interleukin‐19 downregulated mRNA expression of inducible nitric oxide synthase, chemokine C‐C motif ligand 2, and metalloproteinases 2 and 9 without apparent effect on cytokine‐expressing helper or cytotoxic T‐cell differentiation, nor regulatory T cellularity, in the aneurysmal aorta or spleen of interleukin‐19–treated mice. Interleukin‐19 also suppressed AAAs created via angiotensin II infusion in hyperlipidemic mice. CONCLUSIONS: Based on human evidence and experimental modeling observations, interleukin‐19 may influence the development and progression of AAAs. John Wiley and Sons Inc. 2021-08-28 /pmc/articles/PMC8649236/ /pubmed/34459250 http://dx.doi.org/10.1161/JAHA.121.022207 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Tanaka, Hiroki
Xu, Baohui
Xuan, Haojun
Ge, Yingbin
Wang, Yan
Li, Yankui
Wang, Wei
Guo, Jia
Zhao, Sihai
Glover, Keith J.
Zheng, Xiaoya
Liu, Shuai
Inuzuka, Kazunori
Fujimura, Naoki
Furusho, Yuko
Ikezoe, Toru
Shoji, Takahiro
Wang, Lixin
Fu, Weiguo
Huang, Jianhua
Unno, Naoki
Dalman, Ronald L.
Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms
title Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms
title_full Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms
title_fullStr Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms
title_full_unstemmed Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms
title_short Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms
title_sort recombinant interleukin‐19 suppresses the formation and progression of experimental abdominal aortic aneurysms
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649236/
https://www.ncbi.nlm.nih.gov/pubmed/34459250
http://dx.doi.org/10.1161/JAHA.121.022207
work_keys_str_mv AT tanakahiroki recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT xubaohui recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT xuanhaojun recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT geyingbin recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT wangyan recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT liyankui recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT wangwei recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT guojia recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT zhaosihai recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT gloverkeithj recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT zhengxiaoya recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT liushuai recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT inuzukakazunori recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT fujimuranaoki recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT furushoyuko recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT ikezoetoru recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT shojitakahiro recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT wanglixin recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT fuweiguo recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT huangjianhua recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT unnonaoki recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms
AT dalmanronaldl recombinantinterleukin19suppressestheformationandprogressionofexperimentalabdominalaorticaneurysms